Does Mounjaro cause less muscle loss than Ozempic? The 2026 data

TL;DR

In new 2026 studies, the large majority of weight lost on tirzepatide and semaglutide was fat, not muscle, and one semaglutide study even saw grip strength rise. No head-to-head trial proves Mounjaro protects muscle better than Ozempic, and protein plus resistance training remain the real levers.

If you are on Mounjaro or weighing it up, you have almost certainly read that GLP-1 drugs strip away muscle along with fat. The figure that gets repeated is alarming: up to 40% of the weight you lose is lean mass. New 2026 body composition data on tirzepatide, the molecule inside Mounjaro, tells a more reassuring story, and it changes how you should eat and train while the weight comes off.

What the newest tirzepatide data actually found

A 2026 study in Frontiers in Endocrinology followed 35 adults with overweight or obesity on tirzepatide, the drug sold as Mounjaro and Zepbound, for roughly 81 weeks. Doses were escalated in the usual way, starting at 2.5 or 5 mg once weekly and climbing as high as 15 mg. The average participant lost 31.1 kg, about 27.8% of their starting body weight. That headline number is in line with the big tirzepatide trials.

The part worth your attention is where the weight came from. Of every kilogram lost, 85.7% was fat mass. Total body fat dropped by 54.2%, more than halving. Skeletal muscle mass fell by 2.8 kg, an 8.3% decline from each person's starting point. Put simply, the overwhelming share of what left the body was fat, and muscle loss, while real, was a small slice of the total.

Women lost a greater percentage of fat, fat-free mass, and skeletal muscle than men, which tracks with known sex differences in body composition. One caveat matters for reading these numbers: the researchers used bioelectrical impedance (an InBody 770 device) rather than a DEXA scan or MRI. Impedance is convenient but less precise at separating muscle from water and other tissue, so treat the exact percentages as a solid signal, not a laboratory-grade measurement.

How Mounjaro stacks up against Ozempic and Wegovy

The question everyone actually wants answered is whether Mounjaro guards muscle better than Ozempic or Wegovy. A second 2026 study helps frame it. The SEMALEAN study tracked 106 people with obesity on semaglutide 2.4 mg, the Wegovy dose, for 12 months, and measured them with DEXA, the more precise body composition scan.

Those participants lost 12.7% of their body weight over the year. Fat mass fell 18.9%. Lean mass dropped 3.0 kg early on, then stabilised and held steady to month 12. The standout result: average handgrip strength rose by 4.1 kg, and the proportion of people who met the criteria for sarcopenic obesity (low muscle plus excess fat) fell from 49% to 33%. Those people did not just avoid wasting away, they got functionally stronger.

So in both studies the muscle picture looked far better than the old warnings suggest. But here is the honest boundary to hold onto: these are two different studies, in different people, using different tools, over different lengths of time. Impedance measured the tirzepatide group; DEXA measured the semaglutide group. You cannot lay the two side by side and crown a winner. No completed trial has directly compared Mounjaro and Ozempic on body composition. Anyone claiming one clearly beats the other on muscle is reading more into the numbers than is actually there.

Why the "40% muscle loss" number won't die

The scary statistic is not invented. Earlier analyses of GLP-1 weight loss did report that somewhere between a third and 40% of total weight lost was lean mass. The fear of muscle loss on Ozempic and Mounjaro is now one of the most common reasons people hesitate to start. So why the gap with the newer, friendlier figures? Several reasons:

• Lean mass is not the same thing as muscle. On a scan, "lean mass" bundles water, organs, and connective tissue together with skeletal muscle. When fat comes off quickly, you also shed the extra fluid and support tissue that came with carrying it, which inflates the apparent lean loss.
• Some lean loss is normal for any weight loss. Dieting, bariatric surgery, and even exercise-driven fat loss all cost some lean tissue. GLP-1 drugs are not uniquely destructive here. The real question is whether the loss is out of proportion to the fat lost, and the 2026 data suggests it usually is not.
• Measurement methods disagree. DEXA, impedance, and MRI can produce different muscle numbers for the same body on the same day. Older studies and newer ones did not all use the same yardstick.
• Longer follow-up looks better. Most lean mass loss happens in the first months, then levels off, exactly as SEMALEAN showed. A study that stops at six months paints a harsher picture than one that runs a full year.

None of this makes muscle loss a non-issue. Shedding 8.3% of your skeletal muscle, as the tirzepatide group did, is meaningful, and it matters more the older you are or the less muscle you started with. The point is narrower: the "GLP-1 destroys your muscle" framing oversells a manageable risk.

Who needs to worry most, and what to do about it

The people most exposed

Rapid muscle loss is a bigger deal for some users than others. Adults over about 60, anyone already near the threshold for low muscle mass, and people losing weight very fast on higher doses carry the most risk. If that describes you, muscle protection is not optional maintenance, it is the main event. For a younger person with plenty of muscle to spare, the same 8% loss is far less consequential. Of all the GLP-1 side effects that get debated online, muscle loss is one of the few you can measurably influence yourself.

What actually protects muscle

The drug sets the pace of weight loss. What you do around it decides how much of that loss is fat versus muscle. Both 2026 studies flagged the same blind spot: neither could account for how much protein people ate or whether they trained. That is precisely where your control lies. Three habits carry most of the weight:

1. Protein, every single day. Appetite suppression is the whole mechanism of these drugs, which makes it dangerously easy to undereat protein without realising it. Many clinicians suggest roughly 1.2 to 1.6 g of protein per kilogram of body weight during active weight loss, spread across meals. Hitting that target is the single strongest lever for keeping muscle.
2. Resistance training two to three times a week. Lifting weights or doing hard bodyweight work tells your body to hold onto muscle while fat leaves. Walking and other cardio are good for you, but they do not send that "keep the muscle" signal nearly as strongly.
3. Close the nutrient gaps. Eating far less food means less of the raw material your muscle and metabolism run on. Alongside protein, nutrients like vitamin D, magnesium, and vitamin B12 support muscle retention and steady energy, and shortfalls in these become more likely once intake drops. This is also where a lot of the fatigue people report on GLP-1 medications comes from.

This nutrient shortfall is the gap GLP-1 Shield was built to close. The supplements are formulated for people whose food intake has fallen sharply, to help cover the deficiencies that make muscle and energy harder to hold. They are a support for protein and training, not a substitute for either.

Frequently asked questions

Does Mounjaro cause less muscle loss than Ozempic?

There is no head-to-head trial answering this directly. In a 2026 tirzepatide study, 85.7% of weight lost was fat and skeletal muscle fell 8.3%. A separate 2026 semaglutide study found lean mass dropped early then stabilised, with grip strength rising. Both preserved more muscle than older estimates, but different measurement methods mean you cannot rank the two drugs from these studies.

How much of the weight I lose on tirzepatide is muscle?

In a 2026 Frontiers in Endocrinology study of 35 adults on tirzepatide for about 81 weeks, skeletal muscle mass fell 2.8 kg, an 8.3% drop from baseline, while 85.7% of total weight lost came from fat. Your own ratio depends heavily on protein intake and resistance training, which the study could not control for.

Can I keep my muscle while on a GLP-1 medication?

Largely, yes. The 2026 SEMALEAN study found lean mass stabilised after an initial dip and handgrip strength improved over 12 months on semaglutide. Prioritising protein (around 1.2 to 1.6 g per kilogram of body weight) and resistance training two to three times a week are the most reliable ways to protect muscle while you lose fat.

What supplements help protect muscle on Ozempic or Mounjaro?

No supplement replaces protein and strength training, which do the heavy lifting. Beyond adequate protein, nutrients like vitamin D, magnesium, and vitamin B12 support muscle and energy, and deficiencies become more likely as food intake falls sharply on GLP-1 medications. Covering those gaps helps your body hold onto muscle during rapid weight loss.